{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-022503","form_type":"8-K","ticker":"NXGL","cik":"0001468929","company_name":"NEXGEL, INC.","filed_at":"2026-05-12T20:30:25+00:00","discovered_at":"2026-05-12T20:32:00.302255+00:00","generated_at":"2026-05-12T20:39:05.161218+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NEXGEL appoints two Sequence LifeScience leaders to board; Sequence led $5.5M financing","bullets":["Brian J. Kieser (CEO) and Kevin M. Harris (COO) of Sequence LifeScience appointed to NEXGEL board effective May 6, 2026.","Sequence led $5.5M convertible note financing ($0.60/ share conversion, $0.80 warrant) to close Celularity acquisition.","Kieser individually issued $1M convertible note (same terms: $0.60 conversion, $0.80 warrant) on May 11, 2026.","Kieser is indirect sole owner of Sequence; Harris is COO with no equity in Sequence."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-022503","json":"https://secwatch.observer/filing/0001493152-26-022503.json","markdown":"https://secwatch.observer/filing/0001493152-26-022503.md","text":"https://secwatch.observer/filing/0001493152-26-022503.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226022503/0001493152-26-022503-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226022503/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-12T20:39:05.161218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"480b888357","claim":"Kevin M. Harris was appointed as Director at NEXGEL, INC..","evidence_excerpt":"On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the “ Board Appointees ”) were appointed to the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226022503/0001493152-26-022503-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"57d76e73b9","claim":"Brian J. Kieser was appointed as Director at NEXGEL, INC..","evidence_excerpt":"On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the “ Board Appointees ”) were appointed to the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468929/000149315226022503/0001493152-26-022503-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}